NCT07245381 2025-11-24Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing ChemoradiationSheba Medical CenterPhase 1/2 Not yet recruiting65 enrolled
NCT02095119 2015-04-14A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical CancerNational Institute of CancerologíaPhase 1/2 Completed15 enrolled